OpenClinica, an open source EDC system, to hit the Italian market thanks to a new partnership.
Cambridge, MA-June 12th, 2008-Conecta, an Italian open source consulting company, and Akaza Research, developers of OpenClinica, the leading open source Electronic Data Capture (EDC) software, jointly announce a development partnership aimed at bringing OpenClinica and OpenClinica Enterprise to the Italian clinical research market.
"OpenClinica is the most advanced open source EDC system in the market today", said Carlo Daffara, research director at Conecta. "After extensive evaluation, we found the tool to be flexible, complete, and well developed according to best practices in the clinical research software market. The flexibility of open source and the validated approach help in bringing EDC to new markets that have been until now, locked into proprietary and inflexible solutions."
”We are pleased to be working with Conecta,” said Benjamin Baumann, director of business development at Akaza Research. “This partnership will further strengthen OpenClinica’s presence across Europe, allowing more researchers to benefit from a professionally supported open source solution.”
OpenClinica is already in trial use at the Disability Italian Network and the Tuscany Region, in a specialized study based on the WHO ICF protocol, and is being implemented for the Regional Health Care Authority of the Friuli-Venezia Giulia region. An early outcome is the development of an Italian localization of OpenClinica that is expected to be included in the next production release of the product. In addition, the groups will share code and best practices for the dynamic forms and complex validation functionalities.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.